The investment in Biopreparat reflected a Soviet calculus that biological agents could provide asymmetrical leverage against the West. In the depths of the Cold War, the Soviet Union launched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback